Shelton Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-3,143
| Closed | -$249K | – | 763 |
|
|
2020
Q2 | $249K | Buy |
+3,143
| New | +$249K | 0.01% | 505 |
|
|
2020
Q1 | – | Sell |
-3,922
| Closed | -$212K | – | 695 |
|
|
2019
Q4 | $212K | Sell |
3,922
-514
| -12% | -$27.8K | 0.01% | 726 |
|
|
2019
Q3 | $232K | Hold |
4,436
| – | – | 0.01% | 666 |
|
|
2019
Q2 | $214K | Buy |
4,436
+4,212
| +1,880% | +$203K | 0.01% | 737 |
|
|
2019
Q1 | $4.44K | Sell |
224
-4,212
| -95% | -$83.4K | 0.02% | 606 |
|
|
2018
Q4 | $263K | Buy |
4,436
+887
| +25% | +$52.6K | 0.02% | 533 |
|
|
2018
Q3 | $234K | Buy |
+3,549
| New | +$234K | 0.01% | 748 |
|